HIT Consultant
FEBRUARY 28, 2024
Charlotte-Hanneman, CFO at Philips What You Should Know: – Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the appointment of Charlotte Hanneman as its new Chief Financial Officer (CFO). Hanneman brings over 20 years of experience in the MedTech and pharmaceutical industries. – Ms.
Healthcare ECONOMIST
MAY 30, 2023
Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medical technologies, particularly in Eastern Europe and developing countries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
DECEMBER 27, 2021
That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.
Health Populi
OCTOBER 6, 2021
That a pharmaceutical company executive is speaking on the main stage at CES speaks to the category’s mainstreaming beyond elite athletes and smartwatches that track activity. As Ford is quoted in the CES 2022 press release, “CES is the ideal stage to spotlight how technology is allowing people to take control of their health.
Bill Of Health
SEPTEMBER 20, 2022
Dose shortages elevated the role of pharmaceutical executives. The answer to one of the most important public health questions of our time — who gets access to vaccines? The answer to one of the most important public health questions of our time — who gets access to vaccines? — Private decisions did not match public health need.
Health Populi
DECEMBER 19, 2022
For over ten years, digital health technology has been a fast-growing area at the annual CES , the largest convention covering consumer electronics in the world. The company is offering a hearing device integrating deep neural network technology that offers “BrainHearing through the ear” in a customized hearing aid.
Bill Of Health
AUGUST 12, 2021
Activists anticipated the rise of vaccine, therapeutic, and testing nationalism — with rich countries securing preferential access to COVID-19 medical technologies and preventing export to other countries even before they had been approved — and the press soon followed.
Expert insights. Personalized for you.
98 
Let's personalize your content